ErbB-2 protein levels in healthy, asymptomatic women

被引:3
作者
Breuer, B
Smith, S
Osborne, MP
Simmons, RM
Carney, WP
BrandtRauf, PW
机构
[1] NEW YORK HOSP, CORNELL MED CTR, NEW YORK, NY 10021 USA
[2] COLUMBIA UNIV, DIV ENVIRONM HLTH SCI, NEW YORK, NY 10032 USA
[3] ONCOGENE SCI, CAMBRIDGE, MA USA
[4] JEWISH HOME & HOSP AGED, NEW YORK, NY 10025 USA
[5] CUNY MT SINAI SCH MED, DEPT GERIATR & ADULT DEV, NEW YORK, NY 10029 USA
关键词
erbB-2; protein; serum; healthy; women;
D O I
10.3109/13547509609088682
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Recently, a number of studies have found a relationship between having breast cancer and elevated serological levels of the extracellular domain (ECD) of the erbB-2 protein, This study focuses on healthy, asymptomatic women, and evaluates the relationship between serological concentration of the ECD of erbB-2 protein and the following parameters: age, ethnicity, smoking status, age at menarche, age at first live birth, menopausal status, whether surgery had been performed within the prior year, history of breast cancer, history of any other cancer, family history of breast cancer, history of other cancers in first degree relatives, and number of prior benign breast biopsies, Blood samples were stored at -70 degrees C and analysed within 3 weeks of phlebotomy, Statistical analysis indicates that in healthy women, the level of erbB-2 protein in the blood is directly related to age (p = 0.0002) and inversely related to having had a live birth (p = 0.018). The relationship to age is independent of the association between the oncoprotein level and menopausal status. The data indicate that rather than having only one threshold value for serological erbB-2 positivity, it may be necessary to have values that reflect age and nulliparity status.
引用
收藏
页码:141 / 143
页数:3
相关论文
共 16 条
[1]   DETECTION OF C-ERBB-2 RELATED PROTEIN IN SERA FROM BREAST-CANCER PATIENTS - RELATIONSHIP TO ERBB2 GENE AMPLIFICATION AND C-ERBB-2 PROTEIN OVEREXPRESSION IN TUMOR [J].
ANDERSEN, TI ;
PAUS, E ;
NESLAND, JM ;
MCKENZIE, SJ ;
BORRESEN, AL .
ACTA ONCOLOGICA, 1995, 34 (04) :499-504
[2]  
BREUER B, 1994, CANCER EPIDEM BIOMAR, V3, P63
[3]  
CARNEY W P, 1991, Journal of Tumor Marker Oncology, V6, P53
[4]  
DEVIVO I, 1993, MED SCI RES, V21, P345
[5]  
ISOLA JJ, 1994, CANCER, V73, P652, DOI 10.1002/1097-0142(19940201)73:3<652::AID-CNCR2820730324>3.0.CO
[6]  
2-4
[7]   SOLUBLE C-ERBB-2 FRAGMENT IN SERUM CORRELATES WITH DISEASE STAGE AND PREDICTS FOR SHORTENED SURVIVAL IN PATIENTS WITH EARLY-STAGE AND ADVANCED BREAST-CANCER [J].
KANDL, H ;
SEYMOUR, L ;
BEZWODA, WR .
BRITISH JOURNAL OF CANCER, 1994, 70 (04) :739-742
[8]   DETERMINATION OF A FRAGMENT OF THE C-ERBB-2 TRANSLATIONAL PRODUCT P185 IN SERUM OF BREAST-CANCER PATIENTS [J].
KYNAST, B ;
BINDER, L ;
MARX, D ;
ZOLL, B ;
SCHMOLL, HJ ;
OELLERICH, M ;
SCHAUER, A .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1993, 119 (05) :249-252
[9]   ELEVATED SERUM C-ERBB-2 ANTIGEN LEVELS AND DECREASED RESPONSE TO HORMONE-THERAPY OF BREAST-CANCER [J].
LEITZEL, K ;
TERAMOTO, Y ;
KONRAD, K ;
CHINCHILLI, VM ;
VOLAS, G ;
GROSSBERG, H ;
HARVEY, H ;
DEMERS, L ;
LIPTON, A .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (05) :1129-1135
[10]  
LEITZEL K, 1991, Proceedings of the American Association for Cancer Research Annual Meeting, V32, P167